🔎 Trials Near Me

Home › Ulcerative Colitis › Texas › League City

Ulcerative Colitis clinical trials in League City, TX

6 studies for Ulcerative Colitis are looking for participants at sites in and around League City (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RecruitingPhase 4
  • GI Alliance - Webster, Webster · 3 mi away
Ages 18 to 80 · All sexes · Updated Sep 30, 2026 · NCT06581328

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

RecruitingPhase 2
  • Site 009, Webster · 3 mi away
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07012395

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

RecruitingPhase 1/2Healthy volunteers welcome
  • Xencor Investigative Site, Webster · 3 mi away
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT06619990

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

RecruitingPhase 2
  • GI Alliance-Webster, Webster · 3 mi away
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07186101

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

RecruitingPhase 4
  • GI Alliance - Webster, Webster · 3 mi away
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06095128

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RecruitingPhase 2
  • Mirador Therapeutics Selected Site, Webster · 3 mi away
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522

About Ulcerative Colitis

Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.

More about Ulcerative Colitis on MedlinePlus

Ulcerative Colitis trials in other cities

Other studies in League City

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.